Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progesssing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer.
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.